Nuclear brachyury expression is consistent in chordoma, common in germ cell tumors and small cell carcinomas, and rare in other carcinomas and sarcomas: An immunohistochemical study of 5229 cases

American Journal of Surgical Pathology

Volumn 39, Issue 10, 2015, Pages 1305-1312

  Miettinen, Markku ^a   Wang, Zengfeng ^a   Lasota, Jerzy ^a   Heery, Christopher ^a   Schlom, Jeffrey ^a   Palena, Claudia ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Brachyury; Chordoma; Germ cell tumor; Seminoma; Small cell carcinoma

Indexed keywords

BRACHYURY PROTEIN; FETOPROTEIN; T BOX TRANSCRIPTION FACTOR; TUMOR MARKER;

CELL NUCLEUS; CHEMISTRY; CHORDOMA; COMPARATIVE STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; NEOPLASM; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; SARCOMA; SMALL CELL CARCINOMA;

BIOMARKERS, TUMOR; CARCINOMA, SMALL CELL; CELL NUCLEUS; CHORDOMA; FEMALE; FETAL PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SARCOMA; T-BOX DOMAIN PROTEINS;

EID: 84941765467     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000462     Document Type: Article

References (23)

1. Herrmann BG, Labeit S, Poustka A, et al. Cloning of the T gene required in mesoderm formation in the mouse. Nature. 1990;343: 617-622.
2. Edwards YH, Putt W, Lekoape KM, et al. The human homolog T of the mouse T (Brachyury) gene; gene structure, cDNA sequence, and assignment to chromosome 6q27. Genome Res. 1996;6:226-233.
3. Wilkinson DG, Bhatt S, Herrmann BG. Expression pattern of the mouse T gene and its role in mesoderm formation. Nature. 1990;343:657-659.
4. Kispert A, Koschorz B, Herrmann BG. The T protein encoded by Brachyury is a tissue-specific transcription factor. EMBO J. 1995;14:4763-4772.
5. Showell C, Binder O, Conlon FL. T-box genes in early embryogenesis. Dev Dyn. 2004;229:201-218.
6. Martin BL, Kimelman D. Regulation of canonical Wnt signaling by Brachyury is essential for posterior mesoderm formation. Dev Cell. 2008;15:121-133.
7. Yang XR, Ng D, Alcorta DA, et al. T (brachyury) gene duplication confers major susceptibility to familial chordoma. Nat Genet. 2009;41:1176-1178.
8. Presneau N, Shalaby A, Ye H, et al. Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study. J Pathol. 2011;223:327-335.
9. Vujovic S, Henderson S, Presneau N, et al. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol. 2006;209:157-165.
10. Tirabosco R, Mangham DC, Rosenberg AE, et al. Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue. Am J Surg Pathol. 2008;32: 572-580.
11. Lauer SR, Edgar MA, Gardner JM, et al. Soft tissue chordomas: a clinicopathologic analysis of 11 cases. Am J Surg Pathol. 2013;37: 719-726.
12. Sangoi AR, Karamchandani J, Lane B, et al. Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases. Mod Pathol. 2011;24:425-429.
13. Palena C, Polev DE, Tsang KY, et al. The human T-box mesodermal transcription factor brachyury is a candidate target for T-cell-mediated cancer immunotherapy. Clin Cancer Res. 2007;13:2471-2478.
14. Palena C, Roselli M, Litzinger MT, et al. Overexpression of the EMT driver brachyury in breast carcinomas: association with poor prognosis. J Natl Cancer Inst. 2014;106:1-12.
15. Roselli M, Fernando RI, Guadagni F, et al. Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer. Clin Cancer Res. 2012;18:3868-3879.
16. Haro A, Yano T, Kohno M, et al. Expression of Brachyury gene is a significant prognostic factor for primary lung carcinoma. Ann Surg Oncol. 2013;20(suppl 3):S509-S516.
17. Pinto F, Pértega-Gomes N, Pereira MS, et al. T-box transcription factor brachyury is associated with prostate cancer progression and aggressiveness. Clin Cancer Res. 2014;20:4949-4961.
18. Kilic N, Feldhaus S, Kilic E, et al. Brachyury expression predicts poor prognosis at early stages of colorectal cancer. Eur J Cancer. 2011;47:1080-1085.
19. Imajyo I, Sugiura T, Kobayashi Y, et al. T-box transcription factor Brachyury expression is correlated with epithelial-mesenchymal transition and lymph node metastasis in oral squamous cell carcinoma. Int J Oncol. 2012;41:1985-1995.
20. Fernando RI, Litzinger M, Trono P, et al. The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells. J Clin Invest. 2010;120:533-544.
21. Hamilton DH, Fernando RI, Schlom J, et al. Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody. Oncotarget. 2014;10:4853-4862.
22. Yamaguchi H, Niimi T, Kitagawa Y, et al. Brachyury (T) expression in embryonal carcinoma P19 cells resembles its expression in primitive streak and tail-bud but not that in notochord. Dev Growth Differ. 1999;41:253-264.
23. Gokhale PJ, Giesberts AM, Andrews PW. Brachyury is expressed by human teratocarcinoma cells in the absence of mesodermal differentiation. Cell Growth Differ. 2000;11:157-162.